Garrison Bradford & Associates’s Codexis CDXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,000
Closed -$47K 38
2022
Q4
$47K Sell
10,000
-12,500
-56% -$68.5K 0.06% 42
2022
Q3
$136K Buy
22,500
+2,000
+10% +$16.1K 0.17% 42
2022
Q2
$214K Buy
20,500
+8,504
+71% +$107K 0.24% 41
2022
Q1
$247K Hold
11,996
0.24% 47
2021
Q4
$375K Hold
11,996
0.34% 38
2021
Q3
$279K Hold
11,996
0.28% 45
2021
Q2
$272K Buy
11,996
+496
+4% +$10.7K 0.28% 43
2021
Q1
$263K Hold
11,500
0.29% 43
2020
Q4
$251K Hold
11,500
0.31% 42
2020
Q3
$135K Hold
11,500
0.19% 48
2020
Q2
$131K Hold
11,500
0.19% 47
2020
Q1
$128K Sell
11,500
-350
-3% -$4.89K 0.22% 47
2019
Q4
$189K Buy
+11,850
New +$175K 0.24% 50
2019
Q2
Sell
-13,500
Closed -$277K 63
2019
Q1
$277K Buy
+13,500
New +$262K 0.23% 60

Other funds holding CDXS

Garrison Bradford & Associates's CDXS Position: Q1 2023 in Review

Garrison Bradford & Associates sold out of Codexis (CDXS) in Q1 2023, closing a stake of 10,000 shares — an estimated $47K sold.

Garrison Bradford & Associates first reported a position in CDXS in Q1 2019 and held it in 14 quarters. The position peaked at $375K in Q4 2021. 147 funds tracked by Wall St. Rank hold CDXS as of Q1 2023.

  • Garrison Bradford & Associates reported no remaining Codexis position as of Q1 2023 after selling out during the quarter.
  • Garrison Bradford & Associates sold 10,000 Codexis shares in Q1 2023, an estimated $47K.
  • Garrison Bradford & Associates first reported a position in Codexis in Q1 2019 and held it in 14 quarters.
  • Garrison Bradford & Associates's Codexis position peaked at $375K in Q4 2021.
  • 147 funds tracked by Wall St. Rank held Codexis as of Q1 2023.

Based on Garrison Bradford & Associates's 13F filing for Q1 2023, filed 28 Apr 2023.